A detailed history of Janus Henderson Group PLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,323,063 shares of TMO stock, worth $732 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
1,323,063
Previous 1,347,636 1.82%
Holding current value
$732 Million
Previous $715 Million 7.5%
% of portfolio
0.43%
Previous 0.44%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $13 Million - $14.7 Million
-24,573 Reduced 1.82%
1,323,063 $769 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $71.3 Million - $88 Million
-165,204 Reduced 10.92%
1,347,636 $715 Million
Q3 2023

Nov 14, 2023

BUY
$498.29 - $574.41 $15.4 Million - $17.8 Million
30,947 Added 2.09%
1,512,840 $766 Million
Q2 2023

Aug 14, 2023

SELL
$508.46 - $591.13 $589,813 - $685,710
-1,160 Reduced 0.08%
1,481,893 $773 Million
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $32.5 Million - $36.8 Million
-60,823 Reduced 3.94%
1,483,053 $855 Million
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $1.92 Million - $2.26 Million
-3,952 Reduced 0.26%
1,543,876 $850 Million
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $64.4 Million - $76.8 Million
-127,051 Reduced 7.59%
1,547,828 $785 Million
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $4.89 Million - $5.98 Million
-9,769 Reduced 0.58%
1,674,879 $910 Million
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $80.8 Million - $99.5 Million
-154,254 Reduced 8.39%
1,684,648 $995 Million
Q4 2021

Feb 14, 2022

SELL
$569.0 - $667.24 $14.8 Million - $17.4 Million
-26,038 Reduced 1.4%
1,838,902 $1.23 Billion
Q3 2021

Nov 16, 2021

SELL
$509.53 - $609.78 $9.25 Million - $11.1 Million
-18,159 Reduced 0.96%
1,864,940 $1.07 Billion
Q2 2021

Aug 16, 2021

SELL
$441.0 - $508.24 $115 Million - $133 Million
-261,486 Reduced 12.19%
1,883,099 $950 Million
Q1 2021

May 17, 2021

SELL
$439.85 - $518.83 $33 Million - $39 Million
-75,092 Reduced 3.38%
2,144,585 $979 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $162 Million - $196 Million
-371,817 Reduced 14.35%
2,219,677 $1.03 Billion
Q3 2020

Nov 16, 2020

SELL
$359.77 - $441.52 $26.3 Million - $32.3 Million
-73,055 Reduced 2.74%
2,591,494 $1.14 Billion
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $38 Million - $50 Million
138,112 Added 5.47%
2,664,549 $965 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $64.4 Million - $85.7 Million
-252,089 Reduced 9.07%
2,526,437 $716 Million
Q4 2019

Feb 18, 2020

SELL
$271.93 - $328.04 $110 Million - $132 Million
-403,452 Reduced 12.68%
2,778,526 $903 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $52.4 Million - $59.6 Million
195,062 Added 6.53%
3,181,978 $927 Million
Q2 2019

Jul 31, 2019

BUY
$257.51 - $295.55 $143 Million - $164 Million
555,802 Added 22.86%
2,986,916 $877 Million
Q1 2019

Apr 30, 2019

BUY
$212.17 - $273.72 $6.37 Million - $8.22 Million
30,018 Added 1.25%
2,431,114 $665 Million
Q4 2018

Feb 06, 2019

BUY
$208.47 - $251.98 $76.5 Million - $92.5 Million
366,942 Added 18.04%
2,401,096 $537 Million
Q3 2018

Nov 09, 2018

SELL
$205.57 - $244.32 $514,952 - $612,021
-2,505 Reduced 0.12%
2,034,154 $496 Million
Q2 2018

Aug 10, 2018

BUY
$203.14 - $219.53 $6.99 Million - $7.55 Million
34,401 Added 1.72%
2,036,659 $422 Million
Q1 2018

May 14, 2018

SELL
$192.98 - $224.11 $4.85 Million - $5.63 Million
-25,121 Reduced 1.24%
2,002,258 $413 Million
Q4 2017

Feb 09, 2018

BUY
$182.03 - $200.37 $6.15 Million - $6.77 Million
33,782 Added 1.69%
2,027,379 $385 Million
Q3 2017

Nov 14, 2017

SELL
$171.74 - $194.04 $59.8 Million - $67.6 Million
-348,449 Reduced 14.88%
1,993,597 $0
Q2 2017

Aug 17, 2017

BUY
N/A
2,342,046
2,342,046 $409 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $217B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.